


Healthcare Industry News: HIV/AIDS
News Release - February 6, 2008
Vicriviroc Demonstrates Potent and Sustained Viral Suppression Through 48 Weeks of Therapy in Treatment-Experienced HIV-Infected Patients
Source: Schering-Plough
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
